[Etanercept for therapy of rheumatoid arthritis].
Miyasaka
Nobuyuki
N
Department of Medicine & Rheumatology, Graduate School, Tokyo Medical & Dental University.
D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept